A group comparative, placebo-controlled, double-blind trial of the efficacy and safety of galantamine hydrobromide, 7.5 mg (6 mg galantamine base) TID, 10 mg (8 mg galantamine base) TID and 15 mg (12 mg galantamine base) TID taken orally for 12 weeks in patients with a diagnosis of senile dementia of the Alzheimer’s type Posted on October 13, 2017 by tsuperadmin -
NCT00082602 – Galantamine ER Open Label Rapid Dose Escalation Trial in Alzheimer’s Disease Posted on September 20, 2017 by tsuperadmin -
Attainment of treatment goals by people with Alzheimer’s disease receiving galantamine: a randomized controlled trial Posted on September 7, 2017 by tsuperadmin -
NCT00645190 – A Randomized, Double Blind, Active Control, Flexible Dose, Multicenter Study to Evaluate Galantamine HBr in the Treatment of Alzheimer’s Disease: Safety and Effectiveness of an Immediate-release Table Formulation. Posted on September 7, 2017 by tsuperadmin -
NCT02136134 – Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd) vs Bortezomib and Dexamethasone (Vd) in Subjects With Relapsed or Refractory Multiple Myeloma Posted on September 7, 2017 by tsuperadmin -
NCT02076009 – Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed or Refractory Multiple Myeloma Posted on September 7, 2017 by tsuperadmin -
NCT01226459 – A Phase 3, Multi-Center, Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam versus vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) Posted on August 31, 2017 by tsuperadmin -
NCT01145625 – A Phase 3, Multi-Center, Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam versus 2% Minoxidil Solution in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) Posted on August 31, 2017 by tsuperadmin -
NCT00786838 – A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram Posted on August 24, 2017 by tsuperadmin -
NCT00210665 – A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment Posted on August 24, 2017 by tsuperadmin -
The YODA Project